Clinical Trial Update: Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease [NA]

View source ↗

Summary

This clinical trial update discusses how TNF-α promoter polymorphisms and HBV genotype may influence outcomes in HBV-related chronic liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Disease

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Chronic Liver Disease, Hepatocellular Carcinoma | NA | Status: UNKNOWN